Can't Find Baby Formula? Blame Tariffs and the FDA. This crisis is the result of protectionism, regulation, and central planning. Reason · Jun 3, 2022
The FDA urges people to avoid this TikTok trend with avocados TikTok has amassed over 1 billion active monthly users worldwide. The fun-loving social media platform is often at the forefront of trends — whether it's the latest dance craze or useful life hacks. Tribune News Service · Jun 2, 2022
COVID vaccines for children under 5 possible by June 21, White House says The FDA and CDC will still need to authorize the shots. Axios · Jun 2, 2022
Contentious CNN interview about baby formula derailed as camera collapses on set Mr Deese attempted to catch the camera before it tumbled to the ground The Independent UK · Jun 2, 2022
Ban on menthol cigarettes is the wrong move Regulation is critical, and Congress recently took a big step forward by raising the tobacco purchasing age to a national standard of 21. But prohibition doesn’t work. Chicago Sun-Times · Jun 2, 2022
Novavax hopes its COVID shot wins over FDA, vaccine holdouts Americans may soon get a new COVID-19 vaccine option — a more traditional kind of shot known as a protein vaccine The Independent UK · Jun 2, 2022
‘They did, but I didn’t’: Biden denies baby formula makers’ claim shortage was expected in awkward joint briefing ‘I don’t think anyone anticipated the impact of the shutdown of Abbott facility’, Biden says shortly after manufacturers say they expected shortage The Independent UK · Jun 2, 2022
Aeglea BioTherapeutics Shares Plummet Following Refusal To File Letter From FDA Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) announced the U.S. Food and Drug Administration (FDA) has refused to accept the company’s Biologics License Application (BLA) with a Refusal to File (RTF) letter. Benzinga · Jun 2, 2022
PDS Biotechnology Gains On FDA Fast Track Designation For Lead Candidate The U.S. Benzinga · Jun 2, 2022
Cannabis Reg. Update: California's Safe Drug Consumption Sites, FDA's Advisory Panel Discusses CBD In Food & More FDA Advisory Panel To Discuss CBD Use In Food & Dietary Supplements The Science Board of the FDA is scheduled to meet on Tuesday, June 14, to discuss “challenges in evaluating the safety of dietary supplement and food ingredients with predicted pharmacological activity, utilizing cannabinoids as a case study.” Benzinga · Jun 2, 2022
FDA Accepts Myovant Sciences and Pfizer's Filing For Review In Uterine Fibroids Myovant Sciences (NASDAQ: MYOV) and Pfizer (NASDAQ: PFE) received U.S. Benzinga · Jun 2, 2022
Pfizer Seeks FDA Approval For Three Covid Vaccine Doses For Children Below Five Partners Pfizer, Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) urged the FDA to authorize three vaccine doses for children below five, the Wall Street Journal reports. The companies previously asserted that three doses of the shot were 80% effective at preventing symptomatic Covid-19 with robust immune response in children between six months to five years. After mixed results… Benzinga · Jun 2, 2022
62 Biggest Movers From Yesterday Gainers Missfresh Limited (NASDAQ: MF) jumped 51.1% to close at $0.2450 on Wednesday. Benzinga · Jun 2, 2022
Roll Call · Jun 2, 2022 Proposed menthol ban highlights debate over ‘sin tax’ revenue - Roll Call The FDA’s proposed ban on menthol cigarettes means states would see “sin tax” revenues fall, but vaping taxes are already filling the gap.
Tribune News Service · Jun 2, 2022 Pfizer submits COVID-19 shot for children under 5 for FDA authorization WASHINGTON — Pfizer Inc. asked U.S. regulators to clear its COVID-19 vaccine for emergency use in children under age 5, an effort to extend protection against the virus to the country’s youngest.
Tribune News Service · Jun 1, 2022 Baby formula makers tell Biden they knew shortages would be dire WASHINGTON — President Joe Biden defended his administration’s response to a national baby formula shortage, saying he acted as soon he became aware of the crisis in April — even as manufacturers told him Wednesday they saw it coming months earlier.
Benzinga · Jun 1, 2022 DEA Delays Medical Marijuana Clinical Trials Yet Illicit Market Continues To Thrive As states legalize marijuana, some as long as 10 years ago, many are beginning to realize the public health and safety implications of a variety of new high-potency products
Benzinga · Jun 1, 2022 Midatech Pharma's Shares Shoot Higher On FDA Fast Track Designation For Malignant Brain Tumor Drug The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Midatech Pharma PLC's (NASDAQ: MTP) lead drug candidate MTX110 for the treatment of patients with recurrent glioblastoma (rGBM).
The Independent UK · Jun 1, 2022 Pressure growing to remove PFAS from fast food wrappers Environmental and health groups are pushing dozens of fast food companies, supermarkets chains and other retail outlets to remove PFAS from their packaging
Benzinga · Jun 1, 2022 Why Kymera Therapeutics Stock Is Gaining Wednesday The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to Kymera Therapeutics (NASDAQ: KYMR) lead drug candidate KT-333 for the treatment of patients with Peripheral T-cell Lymphoma (PTCL).
Daily Mirror · Jun 1, 2022 Hepatitis outbreak in US linked to infected strawberries as experts issue warning An outbreak of hepatitis A in the United States and Canada has potentially been linked to organic strawberries. What could this mean for the UK?
Reason · Jun 1, 2022 Are Pulse Oximeters "Intrinsically Biased Against People of Color?" A Wall Street Journal article suggests that pulse oximeters mismeasure blood oxygen levels in American minority populations, but the article fails to ask some important questions.
Benzinga · Jun 1, 2022 Australia, New Zealand Express Support To Address USA Baby Food Crisis Australia is in talks with the U.S. to supply baby food, Reuters reports.